Trial Profile
Physical Disability Observational Study in Patients Treated With Betaferon in Daily Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Bayer
- 10 Nov 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 10 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2011 Planned end date changed from 1 Jul 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.